Quantum Surgical: Strategic Analysis of Medical Robotics and European Sovereignty
15 pages · PDF · 30 December 2025 · Licensed single-user copy, watermarked to the buyer
Tactical Military Medical Tech Autonomous Systems, Robotics & Swarms France
€299 excl. VAT — EU VAT calculated at checkout (VAT ID accepted for reverse charge); invoice issued after payment
One click to Stripe — guest checkout, no account. Your download appears on the confirmation page and arrives by e-mail right after payment (link valid 72 hours, up to 5 downloads).
About this report
Quantum Surgical, a Montpellier-based French deep-tech firm founded in 2017, develops the Epione® robotic platform for minimally invasive tumor ablations . Combining medical imaging, AI, and robotics, Epione assists radiologists in planning and executing percutaneous needle ablations for tumors in the abdomen, chest, and musculoskeletal structures.
The company has rapidly commercialized its technology – it holds CE certification in Europe (covering liver, kidney, pancreas, lung, chest and bone cancers) and FDA clearance in the US for abdominal ablations .
Key questions this report answers
- How does the Epione robotic platform combine imaging, AI and robotics for percutaneous tumor ablation?
- How mature is the technology given CE and FDA clearances across multiple cancer indications?
- What partners and markets support commercialisation of the Montpellier firm's medical robotics?
- What capability gaps and dependencies affect Quantum Surgical's dual-use/sovereignty positioning?
Inside this report
- 1. Corporate Identity & Legal Structure
- 2. Strategic Business Profile
- 3. Technology Portfolio Mapping
- 4. Technology Readiness Assessment
- 5. European Strategic Program Participation
- 6. Academic & Research Origins
- 7. Dual-Use Applications & European Market Strategy
- 8. Strategic Partnerships & European Industrial Alliances
- 9. European Market Focus & Operational Domains
- 10. Intellectual Property & European Innovation Assets
- 11. Leadership & European Technical Expertise
- 12. Capability and Gap Analysis
- 13. Strategic Indicators & European Innovation Metrics
- 14. Strategic Priority Alignment
Who it's for
Investors screening Quantum Surgical, competitors and partners assessing their position, and analysts who need a sourced, structured account of the entity and its technology.
Related reports
Methodology, format & delivery
DFM reports are built from primary and official sources — TED procurement notices, CORDIS and the EU Funding & Tenders Portal, EIB operations, the NATO Innovation Fund portfolio, SIPRI data, official budget documents and company disclosures — read together with the underlying legal texts. Sources are cited in the document; it reflects them as of its publication date (30 December 2025). You receive a 15-page PDF, watermarked to you on every page, delivered on the confirmation page and by e-mail immediately after checkout (personal link valid 72 hours, up to 5 downloads). Guest checkout, single-user licence — Terms of Sale.
Related on DFM
More Tactical reports · Military Medical Tech · Autonomous Systems, Robotics & Swarms · All reports
Prefer unlimited access?
Prefer unlimited access? Every report like this is included in the DFM Analysis subscription. See plans →